Skip to main content
Premium Trial:

Request an Annual Quote

Biomedical Boon

The Boston Globe reports that the US stimulus funds has been a good for Massachusetts' biomedical sector. The commonwealth will be receiving $178 million, second only to California's $244 million. According to the Globe:

While the stimulus funds are dwarfed by what Massachusetts researchers get annually from the NIH — $2.25 billion last year — federal funding for biomedical research has been flat for most of this decade, so the new money is having a significant effect at research universities, teaching hospitals, and private labs.

NPR's Health Blog adds that ARRA far-reaching effectis having a . At the University of Guam "a $79,000 stimulus grant to the biology department will allow the purchase of a desktop scanning electron microscope."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.